Makaleler
180
Tümü (180)
SCI-E, SSCI, AHCI (135)
SCI-E, SSCI, AHCI, ESCI (148)
ESCI (12)
Scopus (146)
TRDizin (36)
Diğer Yayınlar (20)
2. (68)Ga-PSMA-11 in Staging of Unfavorable Intermediate- and High-Risk Prostate Cancer Reduces Indication for Noncurative Prostatectomy: A Prospective, Multicenter, International IAEA Study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
, 2025 (SCI-Expanded, Scopus)
8. Acute cytotoxic edema after radioembolization of the liver with Y-90 microspheres observed on DWI in post-therapy Y-90 PET/MRI
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.52, sa.11, ss.3923-3925, 2025 (SCI-Expanded, Scopus)
13. Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
, cilt.66, sa.7, ss.1097-1104, 2025 (SCI-Expanded, Scopus)
15. Prediction of left lobe hypertrophy with voxel-based dosimetry using integrated Y-90 PET/MRI after radioembolization of liver tumors with Y-90 microspheres
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.52, sa.5, ss.1695-1707, 2025 (SCI-Expanded, Scopus)
28. Is the assessment of the mandibular molar danger zone affected by field of view and voxel size in cone beam computed tomography examinations?
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
, cilt.137, sa.6, ss.662-670, 2024 (SCI-Expanded, Scopus)
30. Demonstration of therapy response to radioembolization with 90Y resin microspheres on 68Ga-PSMA PET/MRI in a patient with hepatocellular carcinoma
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.51, sa.1, ss.316-317, 2023 (SCI-Expanded, Scopus)
31. Prognostic Role of F-18 FDG PET in Uterine Cervical Cancer Patients: 10 Years Experience
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, sa.SUPPL 1, 2023 (SCI-Expanded, Scopus)
39. Detectability of 18F-choline PET/MR in primary hyperparathyroidism
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
, cilt.279, sa.5, ss.2583-2589, 2022 (SCI-Expanded, Scopus)
40. Prognostic value of metabolic parameters on baseline 18F-FDG PET/CT in small cell lung cancer
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.66, sa.1, ss.61-66, 2022 (SCI-Expanded, Scopus)
41. Diagnostic Performance and Clinical Impact of 68Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study).
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
, cilt.63, sa.2, ss.240-247, 2022 (SCI-Expanded, Scopus)
47. The position of transarterial chemoembolization with drug-eluting beads and yttrium-90 transarterial radioembolization in patients with hepatocellular carcinoma: Consensus statements from a Delphi-method expert panel in Turkey
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY
, cilt.27, sa.6, ss.732-739, 2021 (SCI-Expanded, Scopus, TRDizin)
49. Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.65, sa.3, ss.282-286, 2021 (SCI-Expanded, Scopus)
56. Predictor of Ga-68 PSMA PET/CT positivity in patients with prostate cancer
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.64, sa.2, ss.226-230, 2020 (SCI-Expanded, Scopus)
69. Evaluation of Chemokine Receptor-4 Expression by 68Ga-Pentixafor PET/CT in Patients with Multiple Myeloma
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.29, sa.4, ss.210-218, 2019 (SCI-Expanded, Scopus, TRDizin)
71. Karaciğer tümörlerinde intraarteriyel mikroküre tedavisi sonuçları
Türkiye Klinikleri
, ss.26-31, 2018 (TRDizin)
73. Threat Analysis and Proposed Solutions for Elekdag Wildlife Development Area
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH
, cilt.51, sa.3, 2017 (SCI-Expanded, Scopus)
75. Ga-68 PSMA Accumulation in Hepatocellular Carcinoma
Journal of Gastroenterology, Pancreatology Liver Disorders
, cilt.4, sa.2, ss.1, 2017 (Hakemli Dergi)
76. A Case of Sarcoidosis: Multiple Osseous Nodule and Thyroid Involvement.
Clinical Research in Pulmonology
, cilt.5, sa.1, ss.1042, 2017 (Hakemli Dergi)
80. Prognostic Importance of Bone Marrow Uptake on Baseline F-18-FDG Positron Emission Tomography in Diffuse Large B Cell Lymphoma
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
, cilt.31, sa.10, ss.361-365, 2016 (SCI-Expanded, Scopus)
89. Effect of the application of prophylactic central compartment lymph node dissection on radioiodine ablation doses in patients with papillary thyroid carcinoma
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.46, sa.4, ss.1078-1082, 2016 (SCI-Expanded, Scopus, TRDizin)
90. Bone mineral density and growth in children with coeliac disease on a gluten free-diet
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.46, sa.6, ss.1816-1821, 2016 (SCI-Expanded, Scopus, TRDizin)
92. The role of baseline Ga-68 DOTATATE positron emission tomography/computed tomography in the prediction of response to fixed-dose peptide receptor radionuclide therapy with Lu-177 DOTATATE
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.46, sa.2, ss.409-413, 2016 (SCI-Expanded, Scopus, TRDizin)
103. The role of 18F FDG PET CT in the primary staging of gastric cancer
Molecular Imaging and Radionuclide Therapy
, cilt.24, sa.1, ss.15-20, 2015 (TRDizin)
110. Prognostic value of metabolic tumor volume measured by 18F FDG PET CT in esophageal cancer patients
Molecular Imaging and Radionuclide Therapy
, cilt.23, sa.1, ss.12-15, 2014 (TRDizin)
121. Clinical Experience of F-18-FDG PET/CT in Soft Tissue and Osseous Sarcomas
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.22, sa.3, ss.163-169, 2012 (SCI-Expanded, Scopus, TRDizin)
124. Differentiated thyroid carcinomas in childhood: clinicopathologic results of 26 patients
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
, cilt.24, sa.9-10, ss.739-742, 2011 (SCI-Expanded, Scopus)
132. Differentiated thyroid corcinomas in childhood: clinicopathologic results of 26 patients
Journal of Pediatric Endocrinology and Metabolism
, cilt.24, sa.9-10, ss.739-742, 2011 (Hakemli Dergi)
133. Ocular involvement in mantlecell lymphoma detected by 18F FDG PET CT
Molecular Imaging and Radionuclide Therapy
, cilt.20, sa.1, ss.36-37, 2011 (Hakemli Dergi)
134. Pediatrik onkolojide nükleer tıp uygulamaları
Türkiye Klinikleri Journal of Pediatr
, cilt.20, sa.2, ss.151-168, 2011 (TRDizin)
137. Five-year follow-up after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
, cilt.36, sa.4, ss.633-643, 2009 (SCI-Expanded, Scopus)
141. Evaluation of extrapulmonary Ga-67 uptake in sarcoidosis: A retrospective analysis
Turkiye Klinikleri Journal of Medical Sciences
, cilt.29, sa.2, ss.375-380, 2009 (SCI-Expanded, Scopus)
143. A rapid lateral flow stool antigen immunoassay and C-14-urea breath test for the diagnosis and eradication of Helicobacter pylori infection in children
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
, cilt.62, sa.4, ss.351-356, 2008 (SCI-Expanded, Scopus)
145. Effect of docetaxel on the surgical tumor microenvironment of head and neck cancer in murine models
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
, cilt.134, sa.7, ss.735-742, 2008 (SCI-Expanded, Scopus)
149. Lymphoscintigraphy in detection of the regional lymph node involvement in gastric cancer
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND
, cilt.88, sa.7, ss.632-638, 2006 (SCI-Expanded, Scopus)
150. A case of systemic lupus erythematosus presenting with protein-losing enteropathy
Turkish Journal of Gastroenterology
, cilt.17, sa.3, ss.226-230, 2006 (SCI-Expanded, Scopus, TRDizin)
170. False-positive Tl-201SPECT in patients with RBBB - Response
CLINICAL NUCLEAR MEDICINE
, cilt.26, sa.7, ss.659, 2001 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
270
1. Variations in F-18-FMISO Physiological Uptake
Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 Ekim 2025, (Tam Metin Bildiri)
3. Correlation Between PRIMARY Scores in Ga-68 PSMA PET and Histological ISUP Grades in Prostate Cancer
Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 Ekim 2025, (Tam Metin Bildiri)
5. Dose-Response Relationship in Patients Who Received TARE with Y-90 Resin Microspheres for Hepatocellular Carcinoma
Annuals Congress of the European Association of Nuclear Medicine, 4 - 08 Ekim 2025, (Tam Metin Bildiri)
6. Pankreasta ve Uterusta Fizyolojik Ga-68 FAPİ Tutulumu
37.Ulusal Nükleer Tıp Kongresi, 9 - 13 Nisan 2025, (Tam Metin Bildiri)
7. Çok Kompartmanlı Dozimetri ile Tekrarlayan Transarteriyel Radyoembolizasyonun Güvenilirliği
37.Ulusal Nükleer Tıp Kongresi, 9 - 13 Nisan 2025, (Tam Metin Bildiri)
8. Karaciğer Tümörlerinin Y-90 Reçine Mikroküreler ile Tedavisi Sonrasında Y-90 PET/MR Görüntülemede Solunum Gating’inin Kullanımı ve Dozimetriye Etkisi
37.Ulusal Nükleer Tıp Kongresi, 9 - 13 Nisan 2025, (Tam Metin Bildiri)
10. Plevral Mezotelyomada İmmünoterapi Öncesi Ga-68 FAPI PET’nin Prognostik Önemi (FAPBI Trial): Ön Sonuçlar
37.Ulusal Nükleer Tıp Kongresi, 9 - 13 Nisan 2025, (Tam Metin Bildiri)
11. Lutesyum-177 (177Lu)-PSMA-617 ile tedavi edilen metastatik kastrasyon dirençli prostat kanseri hastalarında Pan-İmmün inflamasyon değerinin prognostik Rolü
On TARGED Master Oncology, 26 - 29 Ekim 2024, (Tam Metin Bildiri)
12. Transarterial radioembolization (TARE) in Colorectal metastasis of liver (TACOME) trial
Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 Ekim 2024, cilt.51, ss.407-408, (Tam Metin Bildiri)
13. F18-FCH uptake in thyroid parenchymal diseases
Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 Ekim 2024, cilt.51, ss.367-368, (Tam Metin Bildiri)
16. Interim analysis Assessment of Hypoxia before radioembolization treatment with 18F-FMISO PET (ARTE-MISO Tiriol)
Annuals Congress of the European Association of Nuclear Medicine, 19 - 23 Ekim 2024, cilt.51, ss.408-409, (Tam Metin Bildiri)
21. Tare uygulanan hastalarda sol lob hipertrofisinin Y-90 PET/MRG ile yapılan voksel temelli dozimetri ile korelasyonu
36.Ulusal Nükleer Tıp Kongresi, 8 - 12 Mayıs 2024, (Tam Metin Bildiri)
22. Kadmiyum çinko tellür (CdZnTe) kristalli yeni gama prob cihazının performans incelemesi
36.Ulusal Nükleer Tıp Kongresi, 8 - 12 Mayıs 2024, (Tam Metin Bildiri)
23. Transarteriyel radyoembolizasyon öncesi hipoksinin F-18 FMISO/PET ile değerlendirilmesi (ARTE-MISO Trial): Ön Bulgular
36.Ulusal Nükleer Tıp Kongresi, 8 - 12 Mayıs 2024, (Tam Metin Bildiri)
25. Hybrıd F18-FDG PET/MRI in endometrial cancer: staging accuracy, quantitative analysis, and imaging characteristics of histological subtypes
European Congress of Radiology, ECR 2024, Avusturya, 28 Şubat - 03 Mart 2024, (Tam Metin Bildiri)
27. Comparison of 18F-FDG PET/CT and 18F-FDG PET/MRI in detection of liver lesions in hepatocellular carcinoma for staging and restaging
Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 Eylül 2023, (Tam Metin Bildiri)
28. Prognostic role of F-18 FDG PET in uterine cercical cancer patients: 10 years experience
Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 Eylül 2023, (Tam Metin Bildiri)
29. Prognostic value of F-18 FDG PET/CT metabolic parameters in prostate cancer patients
Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 Eylül 2023, (Tam Metin Bildiri)
31. Comparison of 68Ga-DOTATATE PET/CT and 68Ga-DOTATATE PET/MR in detection of neuroendocrine tumour liver metastasis
Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 Eylül 2023, (Tam Metin Bildiri)
33. Voxel-Based dosimetry with integrated Y-90 PET/MRI following TARE with glass microspheres and dose-response relationships - preliminary results
Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 Eylül 2023, (Tam Metin Bildiri)
34. Does peritoneal metastasis evaluation with 18F-FDG PET/MRI contribute to prognosis prediction in patients with ovarian cancer
Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 Eylül 2023, (Tam Metin Bildiri)
35. Uterin serviks kanserli hastalarda 18F-FDG PET'in prognostik yeri: 10 yıllık deneyim.
35.Ulusal Nükleer Tıp Kongresi, 26 Nisan 2023, (Tam Metin Bildiri)
37. Prostat kanserli hastalarda 18F/FDG PET/BT metabolik parametrelerinin prognostik önemi
35.Ulusal Nükleer Tıp Kongresi, 26 Nisan 2023, (Tam Metin Bildiri)
38. PET/MR ile yapılan peritoneal metastaz değerlendirmesi over kanserli hastalarda prognoz tahminine ek katkı sağlıyor mu?
35.Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 26 Nisan 2023, (Tam Metin Bildiri)
39. Hepatoselüler kanserli hastalarda 18F-FDG PET/MR'nin 18F-FDG PET/BT karşılaştırılması
35.Ulusal Nükleer Tıp Kongresi, 26 Nisan 2023, (Tam Metin Bildiri)
41. Nöroendokrin tümör karaciğer metastazlarında 68Ga DOTATATE PET/BT ve PET/MR'in karşılaştırılması
35.Ulusal Nükleer Tıp Kongresi, 26 Nisan 2023, (Tam Metin Bildiri)
44. Head-to-head comparison of 18F-FDG PET/CT and PET/MRI for the imaging of peritoneal recurrence of ovarian carcinoma
Annuals Congress of the European Association of Nuclear Medicine, 2022, Barcelona, İspanya, 15 Ekim 2022, cilt.49, ss.191-192, (Özet Bildiri)
45. DBBHL’Lİ Olguda Nadir Ekstranodal Tutulumlar
34.Ulusal Nükleer Tıp Kongresi, 27 Mart 2022, cilt.8, ss.157-158, (Özet Bildiri)
47. Kardiyak Metastaz Saptanan Dil Kanseri Olgusunda F-18 FDG PET/BT ve MPS Bulguları
34.Ulusal Nükleer Tıp Kongresi, 27 Mart 2022, cilt.8, ss.137-138, (Özet Bildiri)
48. F-18 FCH PET/BT ile Saptanan Tc-99m MIBI Negatif İntratimik Paratiroid Adenomu
34.Ulusal Nükleer Tıp Kongresi, 27 Mart 2022, cilt.8, ss.102, (Özet Bildiri)
49. Added value of F18-FDG PET/MR imaging for detecting liver metastases in patients with colorectal cancer
Annuals Congress of the European Association of Nuclear Medicine, 20 Ekim 2021, cilt.48, ss.184, (Tam Metin Bildiri)
50. Bilateral adrenal masses caused by extramedullary hematopoiesis detected by 18F-FLT PET/CT
23rd Eupopean Congress of Endocrinology 2021, 22 Mayıs 2021, cilt.73, (Tam Metin Bildiri)
51. Bilateral adrenal masses caused by extramedullary hematopoiesis detected bay 18F-FLT PET/CT
23rd Eupopean Congress of Endocrinology 2021, 22 Mayıs 2021, cilt.73, (Özet Bildiri)
52. PETMR in Clinical Practive
Vertual 2021 MEFOMP Medical Physics Congerence, 5 - 07 Nisan 2021
54. Diferansiye tiroid kanseri takibinde F-18-FDG PET/MR’xxnin PET/BT’xxye katkısı
32.Ulusal Nükleer Tıp Kongresi, Türkiye, 20 - 21 Kasım 2020, cilt.6, ss.30-31, (Tam Metin Bildiri)
55. Hepatosellüler kanserde yttrium-90 ıle transarteriyel radyoembolizasyon tedavi yanıtı öngörmede fonksiyonel MR görüntülemenin potansiyel rolü.
41. Ulusal Radyoloji Kongresi, Sanal Kongre Platformu, Türkiye, 24 Ekim - 01 Kasım 2020, (Tam Metin Bildiri)
56. ACCURACY AND RELIABILITY OF MEASUREMENTS OBTAINED FROM 3-DIMENSIONAL RABBIT MANDIBLE MODEL: A MICRO-COMPUTED TOMOGRAPHY STUDY
2. ULUSLARARASI TÜRKİYE VETERİNER ANATOMİ KONGRESİ 11. ULUSAL VETERİNER ANATOMİ KONGRESİ, 26 - 29 Ekim 2019, (Özet Bildiri)
58. Detectability of 18F-Choline PET/MR in primary hyperparathyroidism with negative neck ultrasound and Tc-99m MIBI scintigraphy
Annual Congress of the EANM 2019, 12 - 16 Ekim 2019, cilt.46, (Özet Bildiri)
61. F-18-Choline PET/CT can be a useful tool to differentiate malignant-benign thyroid nodules.
8th Balkan Congress of Nuclear Medicine, 10 - 14 Nisan 2019, ss.16, (Tam Metin Bildiri)
72. 18F-Florokolin ile radioguided paratiroidektomi
21.Ulusal Cerrahi Kongresi, Türkiye, 11 - 15 Nisan 2018, (Özet Bildiri)
73. Prostat kanserinde larinks metastazı: Krikoid kartilajda Ga-68-PSMA tutulumu izlenen ilk olgu
30.Ulusal Nükleer Tıp Kongresi, Türkiye, 11 - 15 Nisan 2018, ss.88, (Tam Metin Bildiri)
75. Baş, boyun kanserli hastaların takibinde 18F-FDG-Positron emisyon tomografisi/bilgisayarlı tomografinin geçerlilik ve güvenilirliği
39.Türk Ulusal Kulak Burun Boğaz ve Baş Boyun Cerrahisi Kongresi, Türkiye, 8 - 12 Kasım 2017, (Tam Metin Bildiri)
76. Analyisi of long-term clinical follow-up outcome, demographic and histopatlological risk factors in a large DTC series
EANM 2017, 21 - 25 Ekim 2017, cilt.44, ss.399, (Özet Bildiri)
77. Analyisi oflong-term clinical follow-up outcome, demographic and histopathological risk factors in a large DTC series
European Association of Nuclear Medicine, 21 - 25 Ekim 2017, cilt.44, ss.395, (Özet Bildiri)
78. The value of volumetric 18F-FDG PET parameters in pediatric patients with bone sarcoma
European Association of Nuclear Medicine, 21 - 25 Ekim 2017, cilt.44, (Özet Bildiri)
79. Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma
Erupoean Association of Nuclear Medicine, 21 - 25 Ekim 2017, cilt.44, (Özet Bildiri)
80. Can serum prostat specific antigen levels be a predictor for 68Ga PSMA PET/CT positivity?
SNMMI 2017 Annual Meeting, 22 - 26 Haziran 2017, cilt.58, ss.1078, (Özet Bildiri)
81. Relationship between baseline metabolic 18F-FDG parameters and survival in malignant pleural mesothelioma
SNMMI 2017 Annual Meeting, 22 - 26 Haziran 2017, cilt.58, ss.149, (Özet Bildiri)
82. Experience of 18F Flourodeoxy glucose (FDG) positron emission tomography (PET) - Computted tomography (CT) in testicular carcinoma
SNMMI 2017 Annual Meeting, 22 - 26 Haziran 2017, cilt.58, ss.1069, (Özet Bildiri)
84. Experience of 18F Flourodeoxy glucose (FDG) positron emission tomography (PET)-computed tomography (CT) in testicular carcinoma
SNM Annual Meeting, Denver, Colorado, Amerika Birleşik Devletleri, 10 - 14 Haziran 2017, cilt.58, ss.1069, (Özet Bildiri)
85. Future liver remnant hypertrophy with Yttrium90Radioembolization in a patient with gastric neuroendocrine tumor liver metastasis
12th Biennial E-AHPBA Congress 2017, Mainz, Almanya, 23 - 26 Mayıs 2017, (Özet Bildiri)
86. Hayvan PET/BT görüntüleme deneyimimiz
29.Ulusal Nükleer Tıp Kongresi, Türkiye, 10 - 14 Mayıs 2017, cilt.3, ss.38, (Özet Bildiri)
87. N-13 Amonyak krdiyak PET görüntüleme: İlk deneyimler
29.Ulusal Nükleer Tıp Kongresi, Türkiye, 10 - 14 Mayıs 2017, cilt.3, ss.66, (Özet Bildiri)
88. N-13 amonyak kardiyak PET görüntüleme: ilk deneyimler
29.Ulusal Nükleer Tıp Kongresi, Antalya, Türkiye, 10 - 14 Mayıs 2017, (Özet Bildiri)
90. Kastrasyon dirençli prostat kanserinde yeni moleküler görüntüleme ve yeni radyonüklid tedavi
Nöroendorkin tümörler ve prostat kanserlerinde ga-68 DOTATATE/Ga-68 PSMA görüntüleme ve Lu-177/Y-90 Tedavisi, Türkiye, 03 Şubat 2017, (Özet Bildiri)
91. The first experience on Lutetium lu 177 prostate specific antigen PSMA treatment in castration resistant prostate cancer patients
Annual Congress of the European Association of Nuclear Medicine, 15 - 19 Ekim 2016
92. Prognostic importance of bone marrow uptake on baseline 18F-FDG positron emission tomograpy/computed tomography in diffuse large B-Cell lymphoma
Annual Congress of the European Association of Nuclear Medicine, 15 - 19 Ekim 2016, cilt.43, ss.317, (Özet Bildiri)
93. The first experience on Lutetium (lu)-177 prostate specigic andigen (PSMA) treatment in castration resistant prostate cancer patients
Annual Congress of the European Association of Nuclear Medicine, 15 - 19 Ekim 2016, cilt.43, ss.415, (Özet Bildiri)
94. Radioembolization with Y 90 resin microspheras for intrahepatic cholangiocelular carcinoma Prognostic factors
Annual Congress of the EANM, 10 - 14 Ekim 2015
97. Solitary colorectal liver metastasis with lower SUV has better survival after selective internal radiation therapy SIRT
Annual Meeting of the European Society of Coloproctology, Dublin, İrlanda, 23 - 25 Eylül 2015, ss.85, (Özet Bildiri)
98. Evaluation of extrapulmonary Ga 67 uptake in sarcoidosis A retrospective analysis
Annual Congress of EANM, Hamburg, Almanya, 25 - 29 Nisan 2015, cilt.28, ss.436, (Özet Bildiri)
100. Impact of PET-CT response on survival parameters following autologous stem cell transplantatiton among patients with multiple myeloma: comparison of two cut-off values
2014 American Society of Hematology Annual Meeting, 6 - 09 Aralık 2014, ss.124, (Özet Bildiri)
102. Diferansiye tiroid kanserlerinde bazal tiroglobulin düzeyleri rekürren ve persistan hastalığı predikte ettirebilir.
6. Türkiye Tiroid Hastalıkları Kongresi, Ankara, Türkiye, 28 - 29 Kasım 2014, (Özet Bildiri)
103. The role of baseline Ga-68 DOTATATE positron emission tomography/computed tomography in the prediction of respon8se to fixed dose peptide receptor radionuclide therapy with Lu-177 DOTATATE
Annual Congress of the European Association of Nuclear Medicine, 18 - 22 Ekim 2014, cilt.41, ss.225, (Özet Bildiri)
106. Hepatoselüler kanserli hastalarda selektif internal radyasyon tedavisi sonrası sağkalımı öngörmede prognostik faktörler
26.Ulusal Nükleer Tıp Kongresi, Türkiye, 16 - 20 Nisan 2014, ss.17, (Özet Bildiri)
107. Lu-177 DOTATATE tedavisine yanıt Ga-68 DOTATATE PET/BT ile tahmin edilebilir mi?
26.Ulusal Nükleer Tıp Kongresi, Türkiye, 16 - 20 Nisan 2014, ss.53, (Özet Bildiri)
108. Meme kanseri karaciğer metastazı nedeniyle selektif internal radyasyon tedavisi uygulanan hastalarda ekstrahepatik metastaz varlığının sağkalım üzerine etkisi
26.Ulusal Nükleer Tıp Kongresi, Türkiye, 16 - 20 Nisan 2014, ss.53, (Özet Bildiri)
109. Lu-177 DOTATATE tedavsine yanıtın metabolik ve radyolojik olarak değerlendirilmesi
26.Ulusal Nükleer Tıp Kongresi, Türkiye, 16 - 20 Nisan 2014, ss.15, (Özet Bildiri)
110. Metastatik kolorektal kanserli hastalarda serum CEA düzeyleri ile 18F- FDG-PET/BT pozitifliği ilişkisi
5.Türk Tıbbi Onkoloji Kongresi, Türkiye, 19 - 23 Mart 2014, (Özet Bildiri)
111. Over kanserli hastalarda serum CA125 düzeyi ile 18F-FDG-PET/BT pozitifliği arasındaki ilişkinin saptanması
5.Türk Tıbbi Onkoloji Kongresi, Türkiye, 19 - 23 Mart 2014, (Özet Bildiri)
112. Meme kanserli hastalarda serum CEA ve CA 15-3 düzeyleri ile 18F-FDG PET/BT pozitifliği arasındaki ilişki
5.Türk Tıbbi Onkoloji Kongresi, Türkiye, 19 - 23 Mart 2014, (Özet Bildiri)
113. Prognostic value of metabolic tumor volume measured by 18F FDG PET CT in esophageal cancer patients
Annual Congres of EANM, 19 - 23 Ekim 2013, cilt.40, ss.363
114. High thyroglobulin levels at remnant ablation may predict recurnet persistent disaese in defferentiated thyroid cancer DTC
37th Annual Meeting of the ETA, Leiden, Hollanda, 7 - 11 Eylül 2013, cilt.2, ss.161, (Özet Bildiri)
115. Basal thyroglobulin levels may predict recurrent and persistend disease in differentiated thyroid cancer DTC
37th Annual Meeting of the ETA, 7 - 11 Eylül 2013, cilt.2, ss.142
117. Metastatik kemik sarkomalı çocuklarda meoadjuvan tedavi ve ona eklenen sorafenib antivegf komniasyonuna yanıtı değerlendirmede Fluorine 18 Fluorodeoksiglukoz positron emission tomograpi 18F PET yönteminin önemi prognoz belirleyici olabilir mi
20.Ulusal Kanser Kongresi, Antalya, Türkiye, 19 - 23 Nisan 2013, ss.37, (Özet Bildiri)
118. REKOMBİNAN TSH ENJEKSİYONU VE LEVOTİROKSİN KESİLMESİ İLE YAPILAN TÜN VÜCUT TARAMA GÖRÜNTÜLERİNİN UYARILMIŞ TİROGLOBULİN DÜZEYLERİNİN HASTALIK REKÜRRENSİ AÇISINDAN RİSK GRUPLARINA GÖRE DEĞERLENDİRİLMESİ
5.TÜRKİYE TİROİD HASTALIKLARI KONGRESİ, Türkiye, 23 - 24 Kasım 2012, (Özet Bildiri)
119. Serviks kanserinin pelvik ve paraaortik lenf nodu evrelemesinde 18F-FDG PET/BT'nin rolü
13.Ulusal Jinekolojik Onkoloji Konresi, Türkiye, 7 - 11 Kasım 2012, ss.82, (Özet Bildiri)
120. The diagnostic role of 68Ga DOTATATE PET CT in the detection of gastroienteropancreatic neuroendocrine tumors comparison with 111In octreotide scintigraphy and CT scan
Annual Congress of EANM, Milan, İtalya, 27 - 31 Ekim 2012, cilt.39, ss.1035, (Özet Bildiri)
121. The role of 18F-FDG PET/CT in pelviv and paraaortic lymph node staging of uterine cervical cancer
Annual Congress of the European Association of Nuclear Medicine, 27 - 31 Ekim 2012, cilt.39, ss.57, (Özet Bildiri)
122. 18F-NaF PET/CT imaging in metastatic bone disease: Preliminary results from Turkey.
Annual Congress of the EANM 2012, 27 Ekim 2012, cilt.39, ss.474, (Özet Bildiri)
128. Effect of prophylactic central lymph node dissection on postoperative stimulated thyroglobulin levels and on disease persistence and recurrence in lymph node negative patients with papillary thyroid carcinoma
36th Annual Meeting of the European Thyroid Association, 8 - 12 Eylül 2012, cilt.1, ss.177
129. The relationship of preoperative TSH levels and coexisting autoimmune thyroid disease with tumor stage at the diagnosis and recurrence in differentiated thyroid carcinoma patients
36th Annual Meeting of the Auropean Thyroid Association, 8 - 12 Eylül 2012, cilt.1, ss.177
131. Evaluation of the response to SIRT in patients with HCC according to pretreatent MAA uptake
SNM Annual Meeting, 9 - 13 Haziran 2012, cilt.53, ss.1151
132. Prognostic importance of 18F FDG uptake pattern of hepatocellular cancer patients who received SIRT
SNM Annual Meeting, 9 - 13 Haziran 2012, cilt.53, ss.439, (Özet Bildiri)
133. 18F-NaF PET/CT imaging in metastatic bone disease: Preliminary results from Turkey.
SNM 2012 Annual Meeting, 09 Haziran 2012, cilt.53, ss.309, (Özet Bildiri)
134. Evaluatio of the response to SIRT in patients with HCC according to pretreatment MAA uptake.
SNM 2012 Annual Meeting, 09 Haziran 2012, cilt.53, ss.227, (Özet Bildiri)
135. Prognostic importance of 18F-FDG uptake pattern of hepatocellular Cancer patients who received SIRT.
SNM 2012 Annual Meeting, 09 Haziran 2012, cilt.53, ss.134, (Özet Bildiri)
137. The role of 68Ga DOTATATE pET CT in detection of distant metastasis in patient with hepatocellular cancer
1st Balkan Congress of Nucl Med, Antalya, Türkiye, 4 - 08 Nisan 2012, ss.79, (Özet Bildiri)
138. The diagnostic role of 68Ga Peptide PET CT in the detection of gastroenteropancreatic neuroendocrine tumors comparison with 111In Octreotide scintigraphy and CT scan
1st Balkan Congress of Nucl Med, Antalya, Türkiye, 4 - 08 Nisan 2012, ss.65, (Özet Bildiri)
139. Evaluation of the responce to SIRT in patients with HCC according to pretreatment MAA uptake
1st Balkan Congress of Nuclear Medicine, 4 - 08 Nisan 2012, ss.27
140. 18F NaF PET CT imaging in metastatic bone disease preliminary results
1st Balkan Congress of Nuclear Medicine, 4 - 08 Nisan 2012, ss.16, (Özet Bildiri)
141. Prognostic importance of 18F-FDG uptake pattern of hepatocellular cancer patients who received SIRT.
1st Balkan Congress 2012, 04 Nisan 2012, ss.27, (Özet Bildiri)
142. 18F-NaF PET/CT imaging in metastatic bone disease: preliminary results
1st Balkan Congress, 2012, 04 Nisan 2012, ss.16, (Özet Bildiri)
143. Evaluation of the response to SIRT in patients with HCC according to pretreatment MAA uptake.
1st Balkan Congress 2012, 04 Nisan 2012, ss.27, (Özet Bildiri)
144. The role of 18F FDG PET CT in the preoperative staging and post therapy follow up Comparison with spiral CT
International Congress on Clinical PET and Molecular Nuclear Medicine, Vienna, Avusturya, 8 - 11 Kasım 2011, ss.86, (Özet Bildiri)
145. Intra arterial radioembolization with Y 90 for unresectable primary and metastatic liver tumours
International Congress on Clinical PET and Molecular Nuclear Medicine, Vienna, Avusturya, 8 - 11 Kasım 2011, ss.199, (Özet Bildiri)
146. The role of PET/CT in the evaluation of panceratic cancer and suspected pancreas masses
International Congerence on Clinical PET and Molecular Nuclear Medicine, 8 - 11 Kasım 2011, ss.87, (Özet Bildiri)
147. The role of 18F-FDG-PET/CT in the preoperative staging and post-therapy up: Comparison with spiral CT.
IPET 2011, 08 Kasım 2011, ss.86, (Özet Bildiri)
149. Impact of 18F FDG PET CT for deecting recurrence of medullary thyroid carcinoma
Annual Congress of EANM, 15 - 19 Ekim 2011, cilt.38, ss.347
150. The role of 18F FDG positron emission tomgraphy computed tomography in detecting carcinoma of unknown primary
Annual Congress of EANM, 15 - 19 Ekim 2011, cilt.38, ss.384
152. The role of 18F-FDG positron emission tomography/computed tomography in detecting carcinoma of unknown primary.
Annual Congress of the EANM 2011, 15 Ekim 2011, cilt.38, ss.384, (Özet Bildiri)
154. Would the thyroglobulin threshold levels specific for evrey center lead to a significant change in the management of DTC patients?
Annual Congress of the EANM 2011, 15 Ekim 2011, cilt.38, ss.347-348, (Özet Bildiri)
156. Impact of 18F FDG PET CT for detecting recurrence of medullary thyroid carcinoma
SNM Annual Meeting, 4 - 08 Haziran 2011, cilt.52, ss.1339
157. Would the thyroglobulin threshold levels specific for every center lead to a significant change in the management of DTC patients
SNM Annual Meeting, 4 - 08 Haziran 2011, cilt.52, ss.1319
158. The impact of 18F FDG PET CT in staging and restagign of multipl myeloma patients Comparison with conventional imaging tools
SNM Annual Meetign, Texas, Amerika Birleşik Devletleri, 4 - 08 Haziran 2011, cilt.52, ss.375, (Özet Bildiri)
159. Impact of 18F FDG positron emission tomography computed tomography for detecting unknown primary tumor
SNM Annual Meeting, Texas, Amerika Birleşik Devletleri, 4 - 08 Haziran 2011, cilt.52, ss.1923, (Özet Bildiri)
160. Primer ya da metastatik karaciğer tümörlerinde intra arteriyal Y 90 mikroembolizasyon tedavisi
8.Ulusal Hepatoloji Kongresi, Türkiye, 1 - 05 Haziran 2011, ss.7
161. Thyroid papillary microcarcinoma and the role of radioiodine treatment
SNM 2011 Annual Meeting, 04 Haziran 2011, cilt.52, (Özet Bildiri)
162. Would the thyroglobulin threshold levels specific for every center lead to a significant change in the management of DTC patients?
SNM 2011 Annual Meeting, 04 Haziran 2011, cilt.52, (Özet Bildiri)
163. Impact of 18F-FDG positron emission tomography/computed tomography for detecting unknown primary tumor.
SNM 2011 Annual Meeting, 4 - 08 Haziran 2011, cilt.52, (Özet Bildiri)
164. Myokard perfüzyon sintigrafisinde adenozin sonuçlarımız
Türkiye Nükleer Tıp Kongresi, Türkiye, 27 Nisan - 01 Mayıs 2011, ss.87
165. Myokard perfüzyon sintigrafisinde adenozin sonuçlarımız.
23.Ulusal Nükleer Tıp Kongresi, 27 Nisan 2011, ss.101, (Özet Bildiri)
166. Diferansiye tiroid kanserli hastalarda hastalık progresyonunu ön görmede erken dönemde kabul edilecek eşik tiroglobulin değerinin önemi.
23.Ulusal Nükleer Tıp Kongresi, 27 Nisan 2011, ss.51, (Özet Bildiri)
167. Myokard perfüzyon sintigrafisi sonuçlarının retrospektif analizi ve koroner anjiografi ili korelasyonu.
23.Ulusal Nükleer Tıp Kongresi, 27 Nisan 2011, ss.100, (Özet Bildiri)
168. The role of PET CT in the evaluation of pancreatic carcer and suspected pancreas masses
Annual Congres of EANM, 9 - 13 Ekim 2010, cilt.37, ss.494
169. Is radioiodine treatment effective for childhood differentiated thyroid carcinomas Results of five years follow up
Annual Congres of EANM, 9 - 13 Ekim 2010, cilt.37, ss.488, (Özet Bildiri)
170. The role of PET/CT in the evaluation of pancreatic cancer and suspected pancreas masses
Annual Congress of the European Association of Nuclear Medicine, 9 - 13 Ekim 2010, cilt.37, ss.432, (Özet Bildiri)
171. The role of PET/CT in the evlauation of pancreatic cancer and suspected pancreas masses.
SNM 2010 Annual Meeting, 09 Ekim 2010, cilt.37, ss.432, (Özet Bildiri)
172. The role of 18f-FDG-PET CT in malign melanome and comporison with conventional imaging modalities.
Annual Congress of the EANM 2010, 09 Ekim 2010, cilt.37, ss.442, (Özet Bildiri)
178. Küçük hücreli dışı akciğer kanserinde preoperatif lenf nodu evrelemesinde 18F FDG PET BT ve dual time görüntülemenin yeri
5.Ulusal Torasik Onkoloji Kongresi, Türkiye, 17 - 19 Haziran 2010, ss.3
179. Differentiated thyroid carcinoma in childhood Clinical experience up to five years follow up period after radioiodine treatment
SNM Annual Meetign, 5 - 09 Haziran 2010, cilt.51, ss.329
180. Long-term effects of gluten free diet on bone mineral density in children with celiac disease
43rd Annual Meeting of ESPGHAN, İstanbul, Türkiye, 09 Haziran 2010, (Özet Bildiri)
181. Differentiated thyroid carcinoma in childhood. Clinical experience up to five years follow up pariod after radioiodine treatment.
SNM 2010 Annual Meeting, 05 Haziran 2010, cilt.51, ss.329, (Özet Bildiri)
183. F 18 FDG PET BT de insidental tiroid uptake inin retrospektif değerlendirilmesi 145 olgu
Türkiye Nükleer Tıp Kongresi, Türkiye, 25 - 29 Nisan 2010, cilt.19, ss.37
184. Medüller tiroid kanseri vakasında 18F FDG PET CT ve 111In Octreotide görüntüleme Olgu sunumu
Türkiye Nükleer Tıp Kongresi, Türkiye, 25 - 29 Nisan 2010, cilt.19, ss.160
185. Non Small Cell akciğer kanserinde preoperatif lenf nodu evrelemesinde 18F FDG PET BT ve dual time görüntülemenin yeri
Türkiye Nükleer Tıp Kongresi, Türkiye, 25 - 29 Nisan 2010, cilt.19, ss.35
186. The role of 18F FDG PET CT in malign melanoma and comparison with conventional imaging modalities
9th International Nuclear Oncology Congress, 25 - 29 Nisan 2010, cilt.19, ss.95
187. Medüller tiroid kanseri rekürrensini saptamada FDG PET BT nin yeri
22.Ulusal Nükleer Tıp Kongresi, Türkiye, 25 - 29 Nisan 2010, ss.158
188. Diferansiye tiroid kanserinde F18 FDG PET BT de saptanan lezyonların SUV larının retrospektif analizi
Türkiye Nükleer Tıp Kongresi, Türkiye, 25 - 29 Nisan 2010, cilt.19, ss.36
189. The role of PET CT in the evaluation of pancreatic cancer and suspected pancreatic masses
9th International Nuclear Oncology Congress, 25 - 29 Nisan 2010, cilt.19, ss.93
190. Myokard perfüzyon sintigrafisi sonuçlarının retrospektif analizi ve koroner anjiografi ile korelasyonu
22.Ulusal Nükleer Tıp Kongresi, Türkiye, 25 - 29 Nisan 2010, ss.86
191. Differansiye tiroid kanserli hastalarda hastalık progresyonunun ön görmede erken dönemde kabul edilecek eşik tiroglobulin değerinin önemi
22.Ulusal Nükleer Tıp Kongresi, Türkiye, 25 - 29 Nisan 2010, ss.9
192. Clinical experience of PET CT in soft tissue and osseos sarcomas
9th International Nuclear Oncology Congres, 25 - 29 Nisan 2010, cilt.19, ss.93
194. The role of PET/CT in the evaluation of pancreatic cancer and suspected pancreatic masses.
9th International Nuclear Oncology Congress, 25 Nisan 2010, cilt.19, ss.93-94, (Özet Bildiri)
195. The role of 18F-FDG-PET/CT in malign melanoma and comparison with conventional imaging modalities.
9th International Nuclear Oncology Congress, 25 Nisan 2010, cilt.19, ss.95, (Özet Bildiri)
196. Clinical experience of PET/CT in soft tissue and osseos sarcomes.
9th International Nuclear Oncology Congress, 25 Nisan 2010, cilt.19, ss.93, (Özet Bildiri)
199. İmmatür teratom takibindeve tedviye yanıtın değerlendirilmesinde 18F-FDG PET/CT: Olgu sunumu.
Ulusal Nükleer Tıp Kongresi, 12 Kasım 2009, (Özet Bildiri)
200. İnsan lenfosit hücreleri üzerine Rheniumun olası genotoksik etkileri in vitro mikronükleus ve FISH analizi ile değerlendirme
XI. Ulusal Tıbbi Biyoloji ve Genetik KOngresi, Bodrum, Türkiye, 28 - 31 Ekim 2009, ss.85
201. The Value of FDG PET CT to Stage Non Small Cell Lung Cancer Ankara University Experience
Annual Congres of EANM, 10 - 14 Ekim 2009, cilt.36, ss.116
202. Treatment of Unresectable Neuroendocrine Liver Tumors with Y 90 Microsphere Ankara University Experience
Annual Congres of EANM, 10 - 14 Ekim 2009, cilt.36, ss.207
203. The Results of Empiric RAI Therapy in 51 DTC pts up to 12 Years Follow up Period Correlation with Histopathology and Tg and Anti Tg Levels
Annual Congres of EANM, 10 - 14 Ekim 2009, cilt.36, ss.600, (Özet Bildiri)
204. Evaluation of Y 90 Microsphere Therapy Response of Metastatic or Primary Liver Tumor with PDG PET CT Ankara University Preliminary Results
Annual Congres of EANM, 10 - 14 Ekim 2009, cilt.36, ss.208
205. Efficiency of High Dose RAI Treatment in Differentiated Thyroid Carcinoma Patients with Positive Serum Tg and or Anti Tg Levels and Negative I 131 WBS
34th Annual Meeting of the European Thyroid Association (ETA), 5 - 09 Eylül 2009, cilt.4, ss.205
206. The Value of 18F FDG PET CT 111In Octreotide and 99mTc MIBI Sc to Detect Recurrence and Metastatic Foci in Differentiated Thyroid Cancer DTC Pts with High Tg and or Anti Tg ATG and Normal I 131 WBS
34th Annual Meeting of the European Thyroid Association (ETA), 5 - 09 Eylül 2009, cilt.4, ss.196
207. 18F Fluorodeoxyglucose Positron Emission Tomography Scanning with Pentagastrin Stimulation for the Identification of Metastases of Medullary Thyroid Carcinoma
34th Annual Meeting of the Eruropean Thyroid Association (ETA), 5 - 09 Eylül 2009, cilt.4, ss.220
208. The Value of Dual Time FDG PET CT to Stage Lymph Nodes Preoperatively in Non Small Cell Lung Cancer
56th SNM Annual Meeting, 13 - 17 Haziran 2009, cilt.50, ss.1799
209. Y 90 Microsphere Therapy in Patients with Hemanjioendothelioma
56th SNM Annual Meeting, 13 - 17 Haziran 2009, cilt.50, ss.1106
210. Potential genotoxic effect of Rhenium 186 on lymphocyte cells in vitro evaluation by micronucleus FISH analysis
1st International Multidisciplinary Cancer Research Congress, Antalya, Türkiye, 21 - 24 Mayıs 2009
211. Lenfoma Hastalarının Evrelemesinde ve Tedavi Takibinde PET BT nin Rolü
21.Ulusal Nükleer Tıp Kongresi, Türkiye, 2 - 05 Mayıs 2009, cilt.18, ss.3
212. Karaciğerde Hemangioendotelyoma Olgusunda Intraarteriyal 90Y Mikroküri Tedavisi
21.Ulusal Nükleer Tıp Kongresi, Türkiye, 2 - 05 Mayıs 2009, cilt.18, ss.114
213. Gastrointestinal Stromal Tümörlerin Tedavi Sonrası Değerlendirilmesinde 18F PET BT nin Yeri
21.Ulusal Nükleer Tıp Kongresi, Türkiye, 2 - 05 Mayıs 2009, cilt.18, ss.44
215. Kadın Genital Tümörlerinde 18F FDG PET BT
21.Ulusal Nükleer Tıp Kongresi, Türkiye, 2 - 05 Mayıs 2009, cilt.18, ss.4
216. When and why performed FDG PET in hodgkin disease
Annuals Congress of EANM, 11 - 15 Ekim 2008, cilt.35, ss.285
217. Value of 18F FDG PET 111In Octreotide and MIBI Scans to Detect Metastatic Foci in DTC Pts with High Tg and or Anti Tg and Normal I 131 WBS
55th SNM Annual Meeting, 14 - 18 Haziran 2008, cilt.49, ss.1118
218. The Usefulness of Scintigraphic Method to Evaluate The Importance of Objective Findings and Subjective Symptoms in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis
55th SNM Annual Meeting, 14 - 18 Haziran 2008, cilt.49, ss.1198
219. FDG PET CT in Female Genital Tumors Comparison with Correlative Imaging
55th SNM annual Meeting, 14 - 18 Haziran 2008, cilt.49, ss.443
220. Kültüre edilmiş insan lenfosit hücreleri üzerine samariumun olası genotoksik etkisi
Uluslararası Katılımlı VIII. Ulusal Tıbbi Genetik Kongresi, Çanakkale, Türkiye, 6 - 09 Mayıs 2008
221. Çocuklarda Helicobakter pylori enfeksiyonunun tanısında ve eradikasyonunun doğrulanmasında hızlı dışkı antijen testi ve C14 Üre nefes testi
8. Ulusal Pediatrik Gastroenteroloji Hepatoloji ve Beslenme Kongresi, Kayseri, Türkiye, 7 - 10 Mayıs 2008, (Özet Bildiri)
222. Tiroid karsinomalı bir olguda tüberkolaza sekonder yanlış pozitif F 18 FDG tutulumu
Türkiye Nükleer Tıp Kongresi, Türkiye, 27 - 30 Nisan 2008, cilt.17, ss.4, (Özet Bildiri)
223. The value of three phase bone scintigraphy and Tc 99m labelled white blood cell imaging to evaluate acute infection
Türkiya Nükleer Tıp Kongresi, Türkiye, 27 - 30 Nisan 2008, cilt.17, ss.36
224. The Value of PET CT for Staging in Head and Neck Carcinoma
20.Ulusal Nükleer Tıp Kongresi, Türkiye, 27 - 30 Nisan 2008, cilt.17, ss.6, (Özet Bildiri)
225. Comparison of Scintigraphic Algorithms for the Diagnosis of Pulmonary Embolism Multi Centre Sutdy for IAEA Coordinated Research Project
Annual Congress of the EANM, 13 - 17 Ekim 2007, cilt.34, ss.547
226. The Retrospective Evaluation of Metastatic Bone Disease in Differentiated Thyroid Carcinoma
Annual Congress of the EANM, 13 - 17 Ekim 2007, cilt.34, ss.457
230. Widespread Nodular Osseous Lesions İn A Sarcoidosis Patient With Thyroid İnvolvement’
17th ERS Annual Congress, 15 - 19 Eylül 2007, cilt.30, (Özet Bildiri)
231. Quantitative lacrimal scintigraphy in Behçet's disease
9th International Congress IOIS, Paris, Fransa, 17 Eylül 2007, (Özet Bildiri)
232. PET CT Imaging in Multiple Myeloma Ankara University Experience Priliminary Results
54th SNM Annual Meeting, 2 - 06 Haziran 2007, cilt.48, ss.1514
233. The Value of In 111 Labeled Octreotide Scintigraphy in NET and In 111 Octreotide Therapy
54th SNM Annual Meeting, 2 - 06 Haziran 2007, cilt.48, ss.1240
234. Determination of Tg Value as an Indicator of Progression Correlations Between Sex Histology Extracapsular Invasion and Progression in Same age Patients with DTC
54th SNM Annual Meeting, 2 - 06 Haziran 2007, cilt.48, ss.1245
235. The value of acei scintigraphy in patients with suspicious renovascular hypertansiyon
XIII.International Symposium of Radionuclides in Nephrourology, 9 - 13 Mayıs 2007, ss.3, (Özet Bildiri)
236. Malign Plevral Mezotelyomalı Hastanın 18F FDG PET BT ile Preoperatif Değerlendirilmesi
19.Ulusal Nükleer Tıp Kongresi, Türkiye, 25 - 29 Nisan 2007, cilt.16, ss.38
237. Kolorektal kanserde 18F FDG PET BT nin değeri
Türkiye Nükleer Tıp Kongresi, Türkiye, 25 - 29 Nisan 2007, cilt.16, ss.7
238. Differansiye tiroid kanserinde metastatik kemik hastalığının retrospektif olarak değerlendirilmesi
Türkiye Nükleer Tıp Kongresi, Türkiye, 25 - 29 Nisan 2007, cilt.16, ss.15
239. F 18 FDG PET BT de yaygın tutulum izlenen sarkoidoz olguları
19.Ulusal Nükleer Tıp Kongresi, Türkiye, 25 - 29 Nisan 2007, cilt.16, ss.40
240. F 18 FDG PET BT de nsidental Rabdomyosarkom Tanımlanan Rektal Karsinom Olgusu
19.Ulusal Nükleer Tıp Kongresi, Türkiye, 25 - 29 Nisan 2007, cilt.16, ss.36
241. Sarkoidoz Tiroid Tutulumu Olan bir Hastada Yaygın Nodüler Kemik Lezyonları
Toraks Derneği 10. Yıllık Kongresi, Türkiye, 25 - 29 Nisan 2007, (Özet Bildiri)
242. Alterations in sternal perfusion after internal thoracic artery harvesting: Mid-term results of scintigraphic study
16th World Congress of the Society of Cardio-Thoracic Surgeons, Ottowa, Kanada, 17 - 20 Ağustos 2006, cilt.1, ss.82, (Özet Bildiri)
243. Clinical Importance of Anti Tg Antibodies in Patients with Differentiated Thyroid Carcinoma
53th SNM Annual Meeting, 3 - 07 Haziran 2006, cilt.47, ss.241
244. Hurthle Cell Carcinoma A Clinicopathologic Study of 13 Cases
Annual Congress of the EANM, 16 - 19 Eylül 2005, cilt.32, ss.603
245. Clinical Evaluation of Tc 99m V DMSA as a Tumour Imaging Agent for Bone Metastases Comparison of Two Tc 99m V DMSA Preparations Preliminary Results
Annual Congress of the EANM, 16 - 19 Eylül 2005, cilt.32, ss.453
246. Result in Patients with Lung Metastasis From Differentiated Thyroid Cancer
Annual Congress of the EANM, 16 - 19 Eylül 2005, cilt.32, ss.211
247. Transepicardial Implantation of Autologous Bone Marrow Mononuclear Cells to Ungraftable Coronary Territories for Patinets with Ischemic Cardiomypathy Safety Efficacy and Outcome
52nd Annual Meeting Scientific Abstracts of the Society of Nuclear Medicine, 18 - 22 Haziran 2005, cilt.46, ss.9
248. Treatment for Microcarcinoma of the Thyroid Clinical Experience
52nd Annual Meeting Scientific Abstracts of the Society of Nuclear Medicine, 16 - 18 Haziran 2005, cilt.46, ss.385
249. Iodine Whole Body Scan Thyroglobulin Levels Technetium 99m MIBI Scan and Computed Tomography Results in Patients with Lung Metastasis From Differentiated Thyroid Cancer
52nd Annual Meeting Scientific Abstracts of the Society of Nuclear Medicine, 16 - 18 Haziran 2005, cilt.46, ss.384
251. Clinical Impact of Technetium 99m Methoxyisobutylisonitrile MIBI Scintigraphy in Differentiated Thyroid Carcinoma Patients with Elevated Thyroglubulin Levels and Negative I 131 Scanning Results
Annual Congress of the EANM, 5 - 08 Eylül 2004, cilt.31, ss.671
252. The Value of Technetium 99m Methosyisobutylisonitrile MIBI Scintigraphy in Differentiated Thyroid Carcinoma Patients with High Tg for Detecting Recurrence and Metastases
Annual Congress of the EANM, 5 - 08 Eylül 2004, cilt.31, ss.701
253. Is Myocardial Perfusion SPECT with Pharmacologic Stres Adequate to Reduce the False Positive Results in Patients with LBBB
Annual Congress of the EANM, 5 - 08 Eylül 2004, cilt.31
254. Is there any Relationship Between Peritumorally Injection Tc 99m MIBI Uptake and Pgp and LRP in Metastatic Sentinel Lymph Node in Breast Cancer
Annual Congress of the EANM, 5 - 08 Eylül 2004, cilt.31, ss.243
255. The Value of Combined Use of Surgical Gamma Probe and Lymphoscintigraphy to Reduce False Negative Results in Detecting Sentinel Lyph Node in Breast Cancer
Annual Congress of the EANM, 5 - 08 Eylül 2004, cilt.31, ss.789
258. Intraoperative Radioisotope Sentinel Lymph Node Mapping in Non Small Cell Lung Cencer
Annual Meeting Scientific Abstracts of the Society of Nuclear Medicine, 19 - 23 Nisan 2004, cilt.45, ss.238
259. Evaluation of Extended Combined 99mTechnetium White Blood Cell Bone Scintigraphy Knee Replacement Infections
Annual Congress of EANM, 24 - 27 Ağustos 2003, ss.378
260. Evaluation of Lateral Hypoperfusion Defects Observed in Thalium 201 Myocardial Perfusion Scintigraphy with MIBI ungated and MIBI Gated SPECT in Hypertensive Patients
Annual Congress of EANM, 24 - 27 Ağustos 2003, ss.249
261. Akut myokard infarktüsü sonrası Tl 201 reverse redistribüsyon
Türkiye Nükleer Tıp Kongresi, Türkiye, 10 - 14 Mayıs 2003, cilt.12, ss.10
262. Nöroblastomada kemik metastazlarının değerlendirilmesinde I 131 MIBG ve kemik sintigrafisinin yeri
Türkiye Nükleer Tıp Kongresi, Türkiye, 10 - 14 Mayıs 2003, cilt.12, ss.128
263. İyi diferansiye tiroid karsinomlu 388 hastada farklı dozlarda I 131 ile ablasyon oranı
Türkiye Nükleer Tıp Kongresi, Türkiye, 10 - 14 Mayıs 2003, cilt.12, ss.133
264. Nöroendokrin tümörlerde In 111 oktreotid sintigrafisi sonuçları
Türkiye Nükleer tıp Kongresi, Türkiye, 10 - 14 Mayıs 2003, cilt.12, ss.127
265. PTCA ve veya CABG sonrasında restenozun değerlendirilmesinde myokard perfüzyon sintigrafisinin yeri Retrospektif analiz
Türkiye Nükleer Tıp Kongresi, Türkiye, 10 - 14 Mayıs 2003, cilt.12, ss.5
267. The assessment of reverse redistribution with Tc 99m MIBI GATED SPECT in acute myocardial infarction
Annual Congress of EANM, 31 Ağustos - 04 Eylül 2002, cilt.30, ss.58
268. Use of lymphoscintigraphy and surgical gamma probe to determine the regional involvement in gastric cancer
Annual Congress of EANM, 31 Ağustos - 04 Eylül 2002, cilt.29, ss.231
269. Tc 99m MIBI SPECT fort he evaluation of response to therapy in brain tumors Preliminary results
Türkiye Nükleer Tıp Kongresi, Türkiye, 1 - 05 Mayıs 2002, cilt.11, ss.47
270. Detection of sentinel nodes with lymphoscintigraphy and surgical gamma probe in four tongue cancer patients
Türkiye Nükleer Tıp Kongresi, Türkiye, 1 - 05 Mayıs 2002, cilt.11, ss.33
Kitaplar
16
1. Nükleer Tıpta Tanı ve Tedavinin Geleceği
Nükleer Tıp ve Moleküler Görüntüleme, Mustafa Kibar, Editör, Akademisyen Kitabevi, ss.1503-1509, 2023
2. Radionuclide Therapy with Alpha-Emitting Agents in Bone Metastasis
Radionuclide Therapy , Recep Bekiş,Berna Polack,Murat Fani Bozkurt, Editör, Springer, London/Berlin , Geneve, ss.339-343, 2022
3. Medüller Tiroid Kanserinde Radyonüklid Görüntüleme ve Radyonüklid Tedaviler
Tiroid Kanseri Güncel Yaklaşım, Prof.Dr.Bekir Çakır, Editör, Akademisyen Kitapevi, ss.521-530, 2020
4. Parkinson Hastalığı Tanısında Nükleer Tıp Görüntüleme Yöntemleri
Hareket Bozuklukları ve Akıl Notları, Muhittin Cenk Akbostancı, Fatma Tuğra Karaarslan Türk, Editör, Güneş Tıp Yayınevi, ss.86-90, 2020
5. Kemik Metastazlarında Alfa Ajanları ile Radyonüklit Tedavi
Radyonüklid Tedavi, Prof.Dr.Recep Bekiş, Prof.Dr.Berna Polack, Prof.Dr.Murat Fani Bozkurt, Editör, O’xxTıp Kitapevi, ss.412-419, 2020
6. Göğüs Hastalıklarında Kullanılan Nükleer Tıp Yöntemleri
Göğüs Hastalıklarında Propedötik, Prof.Dr.Mehmet Karadağ, Prof.Dr.Akın Kaya, Prof.Dr.Tevfik Özlü, Editör, Dünya Tıp Kitapevi, ss.265-276, 2019
7. Nöroendokrin Neoplazilerde Peptid Reseptörlerle Radyonüklid Tedavi ve İzlemi
Türkiye Klinikleri Nükleer Tıp - Özel Konular, Prof.Dr.Zehra ÖZCAN, Editör, Dijital Akademi, Ankara, ss.49-52, 2018
9. Nöroendokrin Neoplazilerde Peptid Reseptörlerle Radyonüklid Tedavi ve İzlemi
Türkiye Klinikleri Nükleer Tıp - Özel Konular, Prof.Dr.Zehra ÖZCAN, Editör, Dijital Akademi, ss.49-52, 2018
10. Tanı ve Tedavide İyotun Kullanımı
Her Yönü ile İyot, SELİM KURTOĞLU,FAHRİ BAYRAM, Editör, M Grup Matbaacılık , Ankara, ss.1-2, 2016
11. Göğüs Hastalıklarında Kullanılan Nükleer Tıp yöntemleri
Gögüs Hastalıkları Propedötik, KAYA AKIN, KARADAĞ MEHMET, ÖZLÜ TEVFİK, Editör, AVES yayıncılık, İstanbul, ss.207-214, 2014
12. Nükleer Tıp
Klinik Onkoloji El Kitabı, YALÇIN B, Editör, Günertıp Kitabevi , Ankara, ss.1, 2013
13. Pozitron Emisyon Tomografisi (PET)/Bilgisayarlı Tomografi (BT) ve Akciğer Hastalıklarında Kullanılan Diğer Nükleer Tıp Yöntemleri
Göğüs Hastalıkları, ÖZLÜ T,METİNTAŞ M,KARADAĞ M,KAYA A, Editör, Rotatıp, Ankara, ss.217-220, 2012
14. Pozitron Emisyon Tomografisi (PET)/Bilgisayarlı Tomografi (BT) ve Akciğer Hastalıklarında Kullanılan Diğer Nükleer Tıp Yöntemleri
Göğüs Hastalıkları, ÖZLÜ T, METİNTAŞ M, KARADAĞ M, KAYA A, Editör, Rotatıp Kitabevi, ss.217-220, 2012
15. Meme Kanserinde Nükleer Tıp Uygulamaları
Meme Kanseri, AYDIN SÜHA,AKÇA TAMER, Editör, Nobel Tıp Kitapevi, Ankara, ss.1-2, 2011
16. Ürolojik Tümörlerde PET'in Güncel Yeri
Ürolojide Yeni Ufuklar Üroonkoloji, BALTACI SÜMER, Editör, Güneştıp Kitabevi, Ankara, ss.1-2, 2009